Skip to main content

Master of Public Health

Tuberculosis Treatment Outcomes among HIV/TB Co-Infected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.

AUTHORS

Carlucci JG , Blevins M , Kipp AM , Lindegren ML , Du QT , Renner L , Reubenson G , Ssali J , Yotebieng M , Mandalakas AM , Davies MA , Ballif M , Fenner L , Pettit AC , , . Journal of acquired immune deficiency syndromes (1999). 2017 2 20; ().

ABSTRACT

Management of tuberculosis (TB) is challenging in HIV/TB co-infected children. The World Health Organization (WHO) recommends nucleic acid amplification tests for TB diagnosis, a four-drug regimen including ethambutol during intensive phase of treatment (IP), and initiation of antiretroviral therapy (ART) within eight weeks of TB diagnosis. We investigated TB treatment outcomes by diagnostic modality, IP regimen, and ART status.

Management of tuberculosis (TB) is challenging in HIV/TB co-infected children. The World Health Organization (WHO) recommends nucleic acid amplification tests for TB diagnosis, a four-drug regimen including ethambutol during intensive phase of treatment (IP), and initiation of antiretroviral therapy (ART) within eight weeks of TB diagnosis. We investigated TB treatment outcomes by diagnostic modality, IP regimen, and ART status.

Tags: